Pommier Y, Poddevin B, Gupta M, Jenkins J
Laboratory of Molecular Pharmacology, National Cancer Institute, NIH, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1601-9. doi: 10.1006/bbrc.1994.2850.
Topoisomerase sites were mapped in the 5'-long terminal repeat of HIV-1 DNA by agarose and sequencing gel electrophoresis. Topoisomerase II sites were observed in the absence and presence of teniposide and amsacrine in the transcription initiation region and the TATA box, consistent with a possible role of topoisomerase II in transcription. The NF-kB and Sp1 regions were poorly cleaved. Topoisomerase I sites were relatively unfrequent even in the presence of camptothecin. They were absent in the core promoter and were concentrated in the TAR and the upstream region near the junction with the host DNA.
通过琼脂糖凝胶电泳和测序凝胶电泳,对HIV-1 DNA 5'长末端重复序列中的拓扑异构酶位点进行了定位。在转录起始区域和TATA框中,无论是否存在替尼泊苷和安吖啶,均观察到拓扑异构酶II位点,这与拓扑异构酶II在转录中可能发挥的作用一致。NF-κB和Sp1区域的切割较少。即使在存在喜树碱的情况下,拓扑异构酶I位点也相对较少。它们在核心启动子中不存在,而是集中在TAR以及与宿主DNA连接处附近的上游区域。